Pilot Trial of Intravenous DP-b99 in the Treatment of First-ever Episode of Non-obstructive Acute High-risk Pancreatitis

Trial Profile

Pilot Trial of Intravenous DP-b99 in the Treatment of First-ever Episode of Non-obstructive Acute High-risk Pancreatitis

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Jul 2015

At a glance

  • Drugs DP b99 (Primary)
  • Indications Pancreatitis
  • Focus Pharmacodynamics
  • Sponsors D-Pharm
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jul 2015 Final results published in D-Pharm media release.
    • 22 Jun 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top